Meeting the Challenge of Vaccination Hesitancy and Acceptance
In 2019, the Sabin-Aspen Science & Policy Group convened with experts from social media platforms, behavioral and cognitive science and multilateral organizations to address the growing issue of vaccine hesitancy. In 2019, the World Health Organization declared vaccine hesitancy one of the top 10 threats to global health. The first six months of 2019 produced more measles cases worldwide than any year since 2006. In bringing together thought leaders from social media and behavioral science with global immunization expertise, the Group worked towards cross-disciplinary approaches to vaccination hesitancy and acceptance.
Meeting the Challenge of Vaccination Hesitancy, a report published in June 2020 by the Sabin-Aspen Vaccine Science & Policy Group, lays out actionable steps that leaders across healthcare, research, philanthropy and technology can take to build confidence in vaccines and vaccinations.
"How to counter vaccine skepticism if a coronavirus vaccine becomes available," is an op-ed published on June 9, 2020, in Fortune Magazine by the co-chairs of the Sabin-Aspen Vaccine Science & Policy Group, Dr. Shirley M. Tilghman, president emerita and professor of molecular biology and public affairs at Princeton University; and Dr. Harvey V. Fineberg, president of the Gordon and Betty Moore Foundation.
 World Health Organization (2019). Top ten threats to global health in 2019. Retrieved from: https://www.who.int/emergencies/ten-threats-to-global-health-in-2019
 Center for Infectious Disease Research and Policy (CIDRAP), University of Minnesota (2019). Global measles outbreaks make 2019 a record-setting year. Retrieved from: http://www.cidrap.umn.edu/news-perspective/2019/08/global-measles-outbreaks-make-2019-record-setting-year
About Sabin-Aspen Vaccine Science & Policy Group
The Sabin-Aspen Vaccine Science & Policy Group brings together senior leaders across many disciplines to examine some of the most challenging vaccine-related issues and drive impactful change. Members are influential, creative, out-of-the-box thinkers who vigorously probe a single topic each year and develop actionable recommendations to advance innovative ideas for the development and distribution of vaccines, as well as evidence-based and cost-effective approaches to immunization. The Sabin-Aspen Vaccine Science & Policy Group (the Group) was founded in 2018, originating from a partnership with the Sabin Vaccine Institute and the Aspen Institute. Emerging from each of these meetings is a set of “Big Ideas”- the Group’s recommendations to bring thought leadership, innovation and transformative changes to the space of vaccines and immunization.